461 – 470 of 3888
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic : The BEAT-IT Study
(
- Contribution to journal › Article
-
Mark
Amyloid formation as a protein phase transition
(
- Contribution to journal › Scientific review
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
-
Mark
Rates of Progression in Patients with Alzheimer’s Disease Depending on Apolipoprotein E Genotype and Concomitant Medications.
2023) 16th Clinical Trials on Alzheimer's Disease Conference(
- Contribution to conference › Poster
-
Mark
Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis
(
- Contribution to journal › Article
-
Mark
Single-cell transcriptomics of human traumatic brain injury reveals activation of endogenous retroviruses in oligodendroglia
(
- Contribution to journal › Article
-
Mark
Cyclosporine as Therapy for Traumatic Brain Injury
(
- Contribution to journal › Scientific review
-
Mark
Reply to Letter to the Editor : “Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up”
(
- Contribution to journal › Letter
-
Mark
Reprogramming Stars #13 : Establishing Connections with Cellular Reprogramming–An Interview with Dr. Daniella Rylander Ottosson
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
(
- Contribution to journal › Article